EN HU

Várkonyi István Zsolt

Publication list

Uploaded publications:
34
Publications in DEA:
34
OA:
15
Date range:
2010-2026
2026
1.
Feketéné Posta, E., Gyarmati, É., Majoros, L., Fekete, I., Várkonyi, I., Zöld, É., Barta, Z.: Across Kingdoms: The Bacteriome, Mycobiome, and Virome in Autoimmune Diseases: Mechanistic Insights, Therapeutic Perspectives, and the Emerging Role of COVID-19.
Nutrients. 18 (12), 1-25, (article identifier: 2032), 2026.
Journal metrics:
D1 Food Science (2025)
Q1 Nutrition and Dietetics (2025)
2.
Szegedi, I., Hodossy-Takács, R., Ali, L. A., Bencs, V., Várkonyi, I., Kozák, M.: Aseptic central nervous system infections: age-related and etiological differences in a ten-year cohort from eastern hungary.
BMC Infect. Dis. [Epub ahead of print], 2026.
Journal metrics:
Q1 Infectious Diseases (2025)
3.
Kozák, M., Mechtler, L., Ralyea, C., Bencs, V., Hodossy-Takács, R., Várkonyi, I.: Headache Attributed to Infection: a Clinical and Pathophysiological Overview.
Curr Pain Headache Rep. 30 (1), (article identifier: 37), 2026.
Journal metrics:
Q1 Anesthesiology and Pain Medicine (2025)
Q1 Medicine (miscellaneous) (2025)
Q2 Neurology (clinical) (2025)
4.
Kozák, M., Sitku, T., Hodossy-Takács, R., Sápi, F., Várkonyi, I., Barta, Z.: Migraine and the Gut?Brain Axis: The Role of Microbiome-Targeted Biotics.
Nutrients. 18 (5), 1-18, (article identifier: 720), 2026.
Journal metrics:
D1 Food Science (2025)
Q1 Nutrition and Dietetics (2025)
5.
Mahdi, M., Al-Muffti, A. S., Linkner, T. R., Miltner, N., Misák, O., Várkonyi, I., Tőzsér, J.: Retrospective neutralization analysis of SARS-CoV-2 variants in early pandemic sera.
Front. Immunol. 17, 1-11, (article identifier: 1797240), 2026.
Journal metrics:
Q1 Immunology (2025)
Q1 Immunology and Allergy (2025)
6.
Kozák, M., Majoros, L., Panyiczki, Z., Bagoly, Z., Hodossy-Takács, R., Dobos, L. V., Várkonyi, I.: Severe vitamin K deficiency-associated coagulopathy triggered by Clostridioides difficile infection and antibiotic-associated dysbiosis: a case report and literature review.
Infection. 54 (3), 1093-1103, 2026.
Journal metrics:
Q1 Infectious Diseases (2025)
Q1 Medicine (miscellaneous) (2025)
Q1 Microbiology (medical) (2025)
7.
Mahdi, M., Bakos, I., Koroknai, A., Kozák, M., Csonka, N., Nagy, A., Várkonyi, I.: Toscana virus infection acquired in Campania, Italy, in a Hungarian traveller: a case report with mini-review.
Trop Dis Travel Med Vaccines. 12 (1), 1-7, (article identifier: 12), 2026.
Journal metrics:
Q2 Infectious Diseases (2025)
Q2 Public Health, Environmental and Occupational Health (2025)
8.
Kozák, M., Majoros, L., Bodnár, F., Hodossy-Takács, R., Hudák, L., Rácz, L., Bencs, V., Várkonyi, I.: When the meningitis-encephalitis panel is negative: off-label joint infection PCR detects CTX-M ESBL-producing Proteus mirabilis in adult meningoencephalitis.
BMC Infect. Dis. 26, 1-9, (article identifier: 1186), 2026.
Journal metrics:
Q1 Infectious Diseases (2025)
2024
9.
Feketéné Posta, E., Fekete, I., Várkonyi, I., Zöld, É., Barta, Z.: The Versatile Role of Peroxisome Proliferator-Activated Receptors in Immune-Mediated Intestinal Diseases.
Cells. 13 (20), 1-31, (article identifier: 1688), 2024.
Journal metrics:
Q1 Biochemistry, Genetics and Molecular Biology (miscellaneous)
2022
10.
Bakos, I., Mahdi, M., Kardos, L., Nagy, A., Várkonyi, I.: Clinical Spectrum and CSF Findings in Patients with West-Nile Virus Infection, a Retrospective Cohort Review.
Diagnostics. 12 (4), 1-9, (article identifier: 805), 2022.
Journal metrics:
Q2 Clinical Biochemistry
2021
11.
Nagy, B. J., Fejes, Z., Szentkereszty, Z., Sütő, R., Várkonyi, I., Ajzner, É., Kappelmayer, J., Papp, Z., Tóth, A., Fagyas, M.: A dramatic rise in serum ACE2 activity in a critically ill COVID-19 patient.
Int. J. Infect. Dis. 103, 412-414, 2021.
Journal metrics:
D1 Infectious Diseases
D1 Medicine (miscellaneous)
D1 Microbiology (medical)
12.
Szekanecz, Z., Bogos, K., Constantin, T., Fülesdi, B., Müller, V., Rákóczi, É., Várkonyi, I., Vályi-Nagy, I.: Antivirális és gyulladásellenes kezelési lehetőségek COVID-19-ben.
Orv. hetil. 162 (17), 643-651, 2021.
Journal metrics:
Q4 Medicine (miscellaneous)
13.
Szekanecz, Z., Bogos, K., Constantin, T., Fülesdi, B., Müller, V., Rákóczi, É., Várkonyi, I., Vályi-Nagy, I.: Gyógyszeres terápiás javaslat COVID-19-ben.
Gyermekgyógy. Továbbk. Szle. 24 (3), 67-74, 2021.
2020
14.
Szekanecz, Z., Bálint, P., Balog, A., Barta, Z., Czirják, L., Géher, P., Kovács, L., Kumánovics, G., Nagy, G., Rákóczi, É., Szamosi, S., Szűcs, G., Vályi-Nagy, I., Várkonyi, I., Constantin, T.: COVID-19: a citokinviharon innen és túl....
Immunol. Szle. 12 (4), 4-14, 2020.
15.
Merkely, B., Szabó, A., Kosztin, A., Berényi, E., Sebestyén, A., Lengyel, C., Merkely, G., Karády, J., Várkonyi, I., Papp, C., Miseta, A., Betlehem, J., Burián, K., Csóka, I., Vásárhelyi, B., Ludwig, E., Prinz, G., Sinkó, J., Hankó, B., Varga, P., Fülöp, G. Á., Mag, K., Vokó, Z., HUNgarian COronaVirus-19 Epidemiological Research (H-UNCOVER) investigators: Novel coronavirus epidemic in the Hungarian population, a cross-sectional nationwide survey to support the exit policy in Hungary.
GeroScience. 42 (4), 1063-1074, 2020.
Journal metrics:
Q1 Aging
Q1 Cardiology and Cardiovascular Medicine
D1 Complementary and Alternative Medicine
D1 Geriatrics and Gerontology
D1 Veterinary (miscellaneous)
2017
16.
Misák, O., Várkonyi, I., Kenéz, É., Rákóczi, É.: Findings of hospital a surveillance-based outcome evaluation study for Clostridium difficile associated colitis.
Final programme 2017, 214, 2017.
17.
Orlos, Z., Rákóczi, É., Misák, O., Lénárt, B., Ócsai, G., Kovács, I., Gorzsás, S., Kardos, L., Lampé, Z., Szilvássy, Z., Várkonyi, I.: Outbreak of anthrax in adults and adolescents: a review of nine cases in a regional teaching hospital in East Hungary.
Clin. Microbiol. Infect. 23 (1), 52-54, 2017.
Journal metrics:
D1 Infectious Diseases
D1 Medicine (miscellaneous)
D1 Microbiology (medical)
2016
18.
Foster, G. R., Coppola, C., Derbala, M., Ferenci, P., Orlandini, A., Reddy, K. R., Tallarico, L., Shiffman, M. L., Ahlers, S., Bakalos, G., Hassanein, T., GUARD-C Study Group: Impact of Safety-Related Dose Reductions or Discontinuations on Sustained Virologic Response in HCV-Infected Patients: results from the GUARD-C Cohort.
PLoS One. 11 (3), e0151703, (article identifier: 0151703), 2016.
19.
Kirsner, R. S., Vanscheidt, W., Keast, D. H., Lantis, J. C., Dove, C. R., Cazzell, S. M., Vartivarian, M., Augustin, M., Marston, W. A., McCoy, N. D., Cargill, D. I., Lee, T. D., Dickerson, J. E., Slade, H. B., HP802-247 Study Group: Phase 3 evaluation of HP802-247 in the treatment of chronic venous leg ulcers.
Wound Repair Regen. 24 (5), 894-903, 2016.
20.
Novák, Z., Yanez, A., Kiss, I., Kuna, P., Tortajada-Girbes, M., Valiente, R., Bilastine Paediatric Safety Study Group: Safety and tolerability of bilastine 10 mg administered for 12 weeks in children with allergic diseases.
Pediatr. Allergy Immunol. 27 (5), 493-498, 2016.
2015
21.
Rákóczi, É., Várkonyi, I.: Antibiotikum használat - jó kezekbe!.
Granum. 18 (3), 15-17, 2015.
22.
Várkonyi, I., Chappey, C., Giraudon, M., Burleigh, L.: A part-randomized study of intravenous oseltamivir in adolescents and adults.
Eur. J. Clin. Microbiol. Infect. Dis. 34 (6), 1181-1188, 2015.
Journal metrics:
Q2 Infectious Diseases
Q1 Medicine (miscellaneous)
Q2 Microbiology (medical)
23.
Gergely, Z., Rákóczi, É., Várkonyi, I.: Pneumonia - és melyik antibiotikum?.
Granum. 18 (3), 18-20, 2015.
24.
Várkonyi, I., Misák, O., Kardos, L., Lampé, Z., Szilvássy, Z., Rákóczi, É.: Prognosis with Proton Pump Inhibitor Versus H2 Blocker Therapy in Clostridium Difficile Infection.
Aperito Journal Of Infectious Diseases And Vaccines. 1 (2), 1-2, 2015.
2014
25.
Rákóczi, É., Várkonyi, I.: Antibiotikum használat - jó kezekbe!.
Granum. 17 (3), 5-7, 2014.
DEENK University of Debrecen
© 2012 University of Debrecen